Literature DB >> 4788212

The determination of dopamine by a modification of the dihydroxyindole fluorimetric assay.

C V Atack.   

Abstract

1. A simplified sensitive fluorimetric assay for dopamine based on the hydroxyindole principle is described. Oxidation of dopamine by ferricyanide and subsequent tautomerization both occur in the same, strongly alkaline, ethanolic solution in the presence of metabisulphite. The reaction is self-regulating, and since times of additions of reagents are relatively unimportant and the final fluorescence is very stable, a large number of samples can be assayed together.2. The method was developed for assaying dopamine in N-ethanolic (50%)-HCl eluates, after purification on a strongly acidic cation exchange column as previously described (Atack & Magnusson, 1970). Portions, up to 1 ml volume, of the 3.5 ml eluate can be taken. No preliminary, time-consuming, neutralization step is required before oxidation. Fluorescence intensity shows a linear relation with concentration for 1-5,000 ng of dopamine per 1.6 ml of final solution, both in pure solutions and in column eluates.3. Fluorescence readings from biological material are given, with evidence for their reproducibility. These, together with other data, demonstrate the relative accuracy of the ;tissue blank' and indicate that amounts of dopamine greater than 3 ng per column can confidently be detected, and amounts greater than 10 ng can be measured quantitatively.4. Fluorescence spectra are presented for the fluorophore derived from authentic dopamine, and from suspected dopamine extracted from spinal cord of normal rats and rats treated with reserpine plus an inhibitor of synthesis. Values for the concentration of dopamine of 20 and <3 ng/g, respectively, were obtained.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4788212      PMCID: PMC1776139          DOI: 10.1111/j.1476-5381.1973.tb08259.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  30 in total

1.  A METHOD FOR THE FLUORIMETRIC DETERMINATION OF 3-METHOXYTYRAMINE IN TISSUES AND THE OCCURRENCE OF THIS AMINE IN BRAIN.

Authors:  A CARLSSON; B WALDECK
Journal:  Scand J Clin Lab Invest       Date:  1964       Impact factor: 1.713

2.  AN IMPROVED METHOD FOR FLUORIMETRIC DETERMINATION OF SMALL AMOUNTS OF ADRENALINE AND NORADRENALINE IN PLASMA AND TISSUES.

Authors:  J HAEGGENDAL
Journal:  Acta Physiol Scand       Date:  1963-11

3.  A SENSITIVE METHOD FOR SPECTROPHOTOFLUOROMETRIC ASSAY OF CATECHOLAMINES.

Authors:  C C CHANG
Journal:  Int J Neuropharmacol       Date:  1964-12

4.  On the use of strong exchange resins for determinations of small amounts of catechol amines.

Authors:  J HAGGENDAL
Journal:  Scand J Clin Lab Invest       Date:  1962       Impact factor: 1.713

5.  The differential determination of catecholamines in urine.

Authors:  B D DRUJAN; T L SOURKES; D S LAYNE; G F MURPHY
Journal:  Can J Biochem Physiol       Date:  1959-10

6.  Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase.

Authors:  A Carlsson; J N Davis; W Kehr; M Lindqvist; C V Atack
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

7.  The fluorometric assay of catecholamines and related compounds: improvements and extensions to the hydroxyindole technique.

Authors:  R Laverty; K M Taylor
Journal:  Anal Biochem       Date:  1968-02       Impact factor: 3.365

8.  Some observations on the estimation of 3-methoxytyramine in brain tissue.

Authors:  H C Guldberg; D F Sharman; P R Tegerdine
Journal:  Br J Pharmacol       Date:  1971-08       Impact factor: 8.739

Review 9.  Dopamine (3-hydroxytyramine) and brain function.

Authors:  O Hornykiewicz
Journal:  Pharmacol Rev       Date:  1966-06       Impact factor: 25.468

10.  A fluorimetric method for the determination of dopamine (3-hydroxytyramine).

Authors:  A CARLSSON; B WALDECK
Journal:  Acta Physiol Scand       Date:  1958-12-15
View more
  101 in total

1.  Brain monoamine synthesis and receptor sensitivity after single or repeated administration of thyroxine.

Authors:  G Engström; U Strömbom; T H Svensson; B Waldeck
Journal:  J Neural Transm       Date:  1975       Impact factor: 3.575

2.  FLA 136: selective agonist at central alpha-adrenoreceptors mediating changes in the turnover of noradrenaline.

Authors:  N E Andén; M Grabowska
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-07       Impact factor: 3.000

3.  Stimulation of beta-adrenergic receptors in the pineal gland increases the noradrenaline stores of its sympathetic nerves.

Authors:  G Jaim-Etcheverry; L M Zieher
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

Review 4.  Alterations in forebrain catecholamine metabolism produced by cerebellar lesions in the rat.

Authors:  S R Snider; R S Snider
Journal:  J Neural Transm       Date:  1977       Impact factor: 3.575

Review 5.  Agonist--antagonist interaction on dopamine receptors in brain, as reflected in the rates of tyrosine and tryptophan hydroxylation.

Authors:  A Carlsson; W Kehr; M Lindqvist
Journal:  J Neural Transm       Date:  1977       Impact factor: 3.575

Review 6.  Interaction of haloperidol and gamma-butyrolactone with (+)-amphetamine-induced changes in monoamine synthesis and metabolism in rat brain.

Authors:  W Kehr; W Speckenbach; R Zimmermann
Journal:  J Neural Transm       Date:  1977       Impact factor: 3.575

7.  Dihydralazine inhibits tyrosine hydroxylase in vivo in the rat.

Authors:  B Persson; T H Svensson; M Henning
Journal:  J Neural Transm       Date:  1982       Impact factor: 3.575

8.  Enhancement of rat brain catecholamine synthesis by administration of small doses of tyrosine and evidence for substrate inhibition of tyrosine hydroxylase activity by large doses of the amino acid.

Authors:  A A Badawy; D L Williams
Journal:  Biochem J       Date:  1982-07-15       Impact factor: 3.857

9.  3-Methoxytyramine and normetanephrine as indicators of dopamine and noradrenaline release in mouse brain in vivo.

Authors:  W Kehr
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

10.  Effect of morphine on dopaminergic neurons in the rat basal forebrain and striatum.

Authors:  P Moleman; J Bruinvels
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.